Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Blood Cancer Journal
|
November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Blood Advances
|
June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Jessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
British Journal of Haematology
|
February 25, 2015
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
Yuko Mishima, Loredana Santo, Homare Eda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy
Chirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Blood Cancer Journal
|
December 23, 2024
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma
Rie Nakamoto-Matsubara, Valentina Nardi, Nora Horick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JCO Precision Oncology
|
September 11, 2020
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring <i>BRAF</i> <sup>V600</sup> Mutations: A Cohort of the Histology-Independent VE-BASKET Study
Noopur Raje, Ian Chau, David M Hyman, et al.
JACC. Cardiovascular Imaging
|
September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Dominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Blood Cancer Journal
|
November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Blood Advances
|
June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Jessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
British Journal of Haematology
|
February 25, 2015
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
Yuko Mishima, Loredana Santo, Homare Eda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy
Chirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Blood Cancer Journal
|
December 23, 2024
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma
Rie Nakamoto-Matsubara, Valentina Nardi, Nora Horick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JCO Precision Oncology
|
September 11, 2020
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring <i>BRAF</i> <sup>V600</sup> Mutations: A Cohort of the Histology-Independent VE-BASKET Study
Noopur Raje, Ian Chau, David M Hyman, et al.
JACC. Cardiovascular Imaging
|
September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Dominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Page
of 10